• About us
• Contact

Advertisement

Organisation › Details

GE Healthcare

GE Healthcare is the $19 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. *

 

	Start	2004-04-08 acquired
	Group	General Electric (Group)
	Predecessor	Amersham (Group) [since 2001]
	Industry	diagnostics (medical/biological)
	Region	Chalfont St. Giles, Buckinghamshire
	Country	United Kingdom (GB)
	Street	Amersham Place Little Chalfont
	City	HP7 9NA Buckinghamshire
	Tel	0870-606-1921
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2018-08-21)
	Currency	USD
	Annual sales	19,000,000,000 (2018 2018-12-31)
		* Document for »About Section«:
		Record changed: 2024-09-01

Advertisement

More documents for General Electric (Group)

• [1] Reig Jofre. (12/20/23). "Press Release: Appointment of Laura Martí as Chief Financial Officer (CFO)". Barcelona....
• [2] Congenica Ltd.. (3/1/21). "Press Release: Congenica Appoints Kamraan Shariff as Chief Business Development Officer". Cambridge....
• [3] Sophia Genetics S.A.. (11/20/19). "Press Release: Sophia Genetics Welcomes Milton Silva-Craig to Its Board of Directors". Boston, MA & Lausanne....
• [4] Rentschler Biopharma SE. (11/6/19). "Press Release: Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub". Laupheim & Milford, MA....
• [5] Leo Pharma A/S. (6/3/19). "Press Release: Leo Pharma Appoints Catherine Mazzacco as New CEO". Ballerup....
• [6] Danaher Corporation. (2/25/19). "Press Release: Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion". Washington, DC....
• [7] Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.